We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Demonstrates the immunogenicity and safety of the 4CMenB vaccine in adults with immunodeficiency, implying effective protection against infection.
4CMenB was immunogenic and well-tolerated in adults with immunodeficiency.
No takes yet. Share an insight, caveat, or question.
Sticchi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: